This product is for R&D purposes only and is not approved for human or veterinary use.
Tirzepatide
Tirzepatide (dual incretin receptor agonist research peptide) is a synthetic peptide analog supplied for use in qualified laboratory and institutional research environments. This product is intended strictly for research purposes only and is formulated to support experimental work exploring incretin biology, receptor-mediated signaling, and metabolic regulation pathways under controlled study conditions.
Research Context
Tirzepatide is an investigational peptide analog widely referenced in metabolic and endocrine research due to its activity across incretin-related receptor pathways. In preclinical and translational research models, incretin signaling is studied for its role in glucose-dependent endocrine responses, appetite-related neuroendocrine pathways, and gastrointestinal physiology. Because dual-pathway modulation is a relevant area of inquiry in metabolic science, tirzepatide is commonly used in laboratory studies designed to examine receptor activation patterns and downstream signaling effects.
Research Overview
Tirzepatide is synthesized to enable controlled evaluation of receptor binding, pathway activation, and pharmacological profiling in vitro and in vivo. Researchers may utilize this compound in cellular assays, receptor signaling studies, and experimental animal models to investigate incretin pathway dynamics, comparative analog performance, and mechanistic hypotheses within approved research frameworks.
Key Research Focus Areas
Incretin Receptor Signaling: Studying receptor activation profiles, intracellular signaling cascades, and response markers in controlled assays.
Metabolic Pathway Research: Investigating experimental models related to glucose regulation, endocrine signaling, and energy balance mechanisms.
Pharmacology & Profiling: Assessing potency, receptor affinity, pathway selectivity, and stability in standardized laboratory systems.
Comparative Studies: Evaluating tirzepatide alongside related incretin analogs to explore mechanistic differences and response patterns.
Product Specifications
Compound Name
Tirzepatide
Purity
≥ 99% (HPLC verified)
Molecular Classification
Synthetic dual incretin analog (research peptide)
Physical Form
Lyophilized (freeze-dried) powder
Net Content
per sterile glass vial
Vial Material
Borosilicate laboratory-grade glass
Appearance
White to off-white solid
Storage Conditions
Store refrigerated at 2–8°C. Protect from light and moisture.
Intended Use
For laboratory research use only. Not for human or veterinary use.
Analytical verification documentation may be available upon request for qualified research institutions.
This compound is provided in a research-grade formulation intended to support stability, consistency, and reproducibility in laboratory workflows. Researchers should follow institutional safety standards, ethical protocols, and approved handling procedures when conducting studies involving tirzepatide.
For research use only. Not for human or animal consumption.
This product has multiple variants. The options may be chosen on the product page
BATS Testing in progress
CERTIFICATE OF ANALYSIS COMING SOON
This product is currently undergoing third-party batch testing at our U.S.-based laboratory. The Certificate of Analysis will be published here once verification is complete.
COAs are typically available within a few business days of a new batch release.